Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > ASCO Presentation - 28% CR at 450 Days

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Feb 18, 2023 10:44am

187 Views

Post# 35293600

RE:RE:RE:RE:RE:ASCO Presentation - 28% CR at 450 Days

Nice Eoga,

I wish Ferrin was publicly traded so we could all see the effect on their SP of FDA approval.

TLT's 1433 should be a bit cheaper, is less toxic, is standalone, and requires fewer treatments that are less invasive... :-)

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?